内容紹介
Recurrent Hepatocellular Carcinoma
Summary
Long-term prognosis after curative resection or local ablation therapy in patients with hepatocellular carcinoma(HCC)remains unsatisfactory because of a high recurrence rate. The prognosis of these patients depends on the effectiveness of treatment for recurrent HCC. It is recommended that the treatment policy for recurrent HCC is based on the same criteria as that for primary HCC. Repeat hepatectomy is advisable for patients with less than 3 hepatocellular carcinomas who have good liver function(patients with non-cirrhotic livers or Child-Pugh class A cirrhosis).
要旨
近年,肝細胞癌に対する肝切除,局所療法の生存率は改善しているものの治療後の再発率は高く,再発後の治療効果が患者の予後を左右する。再発肝細胞癌に対しては初回肝細胞癌に対するのと同じ基準で治療方針を決定することが望ましく,肝機能良好例で3個以内では再肝切除が推奨される。
目次
Summary
Long-term prognosis after curative resection or local ablation therapy in patients with hepatocellular carcinoma(HCC)remains unsatisfactory because of a high recurrence rate. The prognosis of these patients depends on the effectiveness of treatment for recurrent HCC. It is recommended that the treatment policy for recurrent HCC is based on the same criteria as that for primary HCC. Repeat hepatectomy is advisable for patients with less than 3 hepatocellular carcinomas who have good liver function(patients with non-cirrhotic livers or Child-Pugh class A cirrhosis).
要旨
近年,肝細胞癌に対する肝切除,局所療法の生存率は改善しているものの治療後の再発率は高く,再発後の治療効果が患者の予後を左右する。再発肝細胞癌に対しては初回肝細胞癌に対するのと同じ基準で治療方針を決定することが望ましく,肝機能良好例で3個以内では再肝切除が推奨される。